U.S. to launch $36 million AIDS vaccine trial

Published: 9 July 2002 y., Tuesday
About 16,000 HIV-negative volunteers will participate in the five-year study, to be co-sponsored by the U.S. National Institute of Allergy and Infectious Diseases and the Thai Ministry of Public Health. Because it will take place in Thailand, the trial has been dubbed the "Thai Vaccine Trial." Over six months, half of the participants will receive a series of three "primer" shots and two "booster" shots; the other half will receive placebo. The "prime" part of the vaccine, called ALVAC-HIV, is made by Aventis Pasteur and the "boost," called AIDSVAX-B/E, is made by VaxGen. Both medications have been studied independently and have generated strong safety records. Dr. Anthony Fauci, chairman of NIAID, expressed optimism.
Šaltinis: cnn.com
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.

Facebook Comments

New comment


Captcha

Associated articles

The most popular articles

Swine flu: lessons to learn from "disproportionate" EU response

With the new influenza season underway, MEPs have criticised the EU's "disproportionate" response to the outbreak of the H1N1 ("swine flu") virus in 2009-2010. more »

Health in the EU: Nutrition deemed a growing challenge for health in the EU and beyond

Over half the EU adult population is now overweight or obese according to the “Health at a Glance: Europe 2010” report published by the European Commission and the OECD today. more »

Suspected cholera outbreak in Haiti

Over 130 people die in central Haiti due to a suspected outbreak of cholera. more »

Hearing on lessons of Influenza A (H1N1) pandemic

The Influenza A (H1N1) pandemic returned to the Parliament last week but fortunately not in the literal sense. more »

Food: Commission reviews the progressive adoption of the list of permitted health claims

The Commission announced today its intention to restructure the process of progressive adoption of the list of permitted health claims on food products (also known as “Article 13 claims”). more »

Protecting patients: EU to upgrade medicine safety monitoring

Patients will be better informed on how to use medicines, and enabled to report their adverse effects directly to national authorities, thanks to updates of EU laws agreed with the Council and endorsed by Parliament on Wednesday. more »

Peru battles rabies and the plague

Doctors in Peru are facing outbreaks of two killer diseases, rabies and the plague, being spread by bats and rats. more »

Drug experts warn of 'superbug'

Scientists warn a new drug-resistant superbug could spread worldwide, fuelled in part by medical tourism. more »

New milk health scare in China

Chinese officials say they are investigating reports that tainted milk powder has caused premature sexual development in baby girls. more »

Woman to sell baby for medical bill

A woman in India says she has to sell her 6-month-old baby in order to pay her husband's medical expenses. more »